4.7 Review

Anti-Laminin 332-Type Mucous Membrane Pemphigoid

Journal

BIOMOLECULES
Volume 12, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/biom12101461

Keywords

mucous membrane pemphigoid; cicatricial pemphigoid; laminin 332; diagnosis; treatment; tumor

Ask authors/readers for more resources

Anti-LM332-type mucous membrane pemphigoid is a rare autoimmune bullous disease that is difficult to diagnose and treat, and may be correlated with tumors.
Anti-laminin (LM) 332-type mucous membrane pemphigoid (MMP) is a rare autoimmune bullous disease and was originally discovered as anti-epiligrin cicatricial pemphigoid. Anti-LM332-type MMP has clinical manifestations similar to those of other types of MMP and can only be distinguished through the detection of circulating autoantibodies against LM332. Our group and others have established a number of immunological methods with varying sensitivity and specificity for detection of anti-LM332 autoantibodies; however, none of the established methods has been widely used for clinical diagnosis. There is currently no unified standard treatment, and it is very difficult to completely cure anti-LM332-type MMP. In addition, an increasing body of evidence suggests that there may be a strong correlation between anti-LM332-type MMP and tumors. In this article, we review the current progression of diagnosis and treatment of anti-LM332-type MMP, as well as the possible correlation between anti-LM332-type MMP and tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available